drugset / Trial / NCT03645408
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Phase 1
Terminated
8 enrolled
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
A double-blind, randomized, placebo-controlled, crossover design trial was used to test the effect of exenatide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this research was to determine whether exenatide has effects on alcohol consumption.
Timeline
- Start
- 2019-05-02
- Primary completion
- 2021-07-01
- Completion
- 2021-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 5 ug | Other |